In addition, Xiao and colleagues tested the samples of peripheral blood or bone marrow specimens obtained from patients suffering from chronic myeloid leukemia and showed that the frequency of loss-of-function mutations of the NQO1 gene was higher than that in healthy individuals. This evidence concerns the gene NQO1 and chronic myelogenous leukemia, BCR-ABL1 positive.